NCT02620657已完成不适用
A Retrospective Study on Real-world EGFR Mutation Testing Practice Status and Impact Factors in Patients With Advanced NSCLC in North China
ying cheng0 个研究点目标入组 2,809 人开始时间: 2015年12月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,809
- 主要终点
- To investigate the proportion of advanced NSCLC patients who performed EGFR mutation test
研究概览
简要总结
Approximately 3000 advanced NSCLC patients, who fulfil the inclusion/exclusion criteria, will be recruited by 30 sites in North China.
详细描述
Approximately 3000 advanced NSCLC patients will be recruited , and the medical information of recruited patients must be recorded in the hospital electronic system from Jan 1st 2014 to Dec 31st 2014 .The study will focus on the EGFR testing rate in adenocarcinoma patients，so the collecting data for non-adenocarcinoma patients will be controlled in less than 10% for each site.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histological or cytological confirmed NSCLC;
- •Patients were diagnosed with advanced NSCLC from Jan 1st 2014 to Dec 31st 2014;
- •Researchers should collect the records of consecutive NSCLC patients in each site.
排除标准
- •Any patients without NSCLC diagnosis;
- •Any patients which were diagnosed with advanced NSCLC before Jan 1st 2014 or after Dec 31st 2014.
结局指标
主要结局
To investigate the proportion of advanced NSCLC patients who performed EGFR mutation test
时间窗: 2014.01.01-2014.12.31
次要结局
未报告次要终点
研究者
ying cheng
Director of Jilin Cancer Hospital
Guangdong Association of Clinical Trials
相似试验
Unknown
不适用
A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation StatusNSCLCNCT01100827National University Hospital, Singapore
已完成
不适用
EGFR Mutations on ctDNA in Patients With Advanced NSCLCNon-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer MetastaticNCT02623257First People's Hospital of Hangzhou1,055
已完成
不适用
Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).NSCLC (Non-small Cell Lung Cancer)NCT03562819AstraZeneca268
Unknown
不适用
cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia ChinaNonsmall Cell Lung CancerAdenocarcinomaNCT02980536Berry Genomics Co., Ltd.129
已完成
不适用
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)Non Small Cell Lung CancerNCT01081496AstraZeneca1,000